Clinical and Economic Assessment in Early-Stage Dementia by Severity and Amyloid-β Status: A 5-Year Retrospective Claims Study of GERAS-US Patients

Manuscript Number: 

22-0415R3

Author(s): 
Julie Chandler, Joanna Kubisiak

Disclosures

Julie Chandler

  • Equity:
    I am a minor stockholder in Eli Lilly and Co who who funded this scientific investigation.
    Sponsors:
    I am a scientific researcher employed by Eli Lilly and Co

Joanna Kubisiak

  • Equity:
    I am an employee of Westat, which is an employee owned company; as an employee I have stock ownership in the company.